Concepedia

Publication | Open Access

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

DOIFull Paper Access

416

Citations

25

References

2008

Year

Song‐Ping Han, Deborah Hagan, Joseph R. Taylor, Li Xin, Wei Meng, Scott A. Biller, John R. Wetterau, William N. Washburn, Jean M. Whaley
Diabetes

Abstract

These data suggest that dapagliflozin has the potential to be an efficacious treatment for type 2 diabetes.

References

YearCitations

Page 1